Progression of autosomal-dominant polycystic kidney disease in children.

BACKGROUND Although many case reports describe manifestations of autosomal-dominant polycystic kidney disease (ADPKD) in children, no longitudinal studies have examined the natural progression or risk factors for more rapid progression in a large number of children from ADPKD families. METHODS Since 1985, we have studied 312 children from 131 families with a history, a physical examination, blood and urine chemistries, an abdominal ultrasonography, and gene linkage analysis. One hundred fifteen of 185 affected children were studied multiple times for up to 15 years. Renal volumes were determined by ultrasound imaging. Graphs of mean renal volumes according to age were compared between affected and unaffected children, ADPKD children with and without early severe disease, and children with and without high blood pressure. RESULTS Affected children had faster renal growth than unaffected children. ADPKD children with severe renal enlargement at a young age continued to experience faster renal growth than those with mild enlargement or normal kidney size for their age, and affected children with high blood pressure had faster renal growth than those with lower blood pressure. Glomerular filtration rate did not decrease in any children except for two with unusually severe early onset disease. CONCLUSIONS The progression of ADPKD clearly occurs in childhood and manifests as an increase in cyst number and renal size. This study identifies children at risk for rapid renal enlargement who may benefit the most from future therapeutic interventions.

[1]  Ann M. Johnson,et al.  Anatomic and metabolic risk factors for nephrolithiasis in patients with autosomal dominant polycystic kidney disease. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[2]  Ann M. Johnson,et al.  Renal asymmetry in children with autosomal dominant polycystic kidney disease. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[3]  Ann M. Johnson,et al.  Factors relating to urinary protein excretion in children with autosomal dominant polycystic kidney disease. , 1998, Journal of the American Society of Nephrology : JASN.

[4]  B. Lifson,et al.  Role and long-term results of laparoscopic decortication in solitary cystic and autosomal dominant polycystic kidney disease. , 1998, The Journal of urology.

[5]  Ann M. Johnson,et al.  Identification of patients with autosomal dominant polycystic kidney disease at highest risk for end-stage renal disease. , 1997, Journal of the American Society of Nephrology : JASN.

[6]  T. Seeman,et al.  Blood pressure and renal function in autosomal dominant polycystic kidney disease , 1997, Pediatric Nephrology.

[7]  Dan Wang,et al.  The pathogenesis of hypertension in autosomal dominant polycystic kidney disease , 1997, Journal of hypertension.

[8]  G. Hawksworth,et al.  Selective antagonism of the AT1 receptor inhibits angiotensin II stimulated DNA and protein synthesis in primary cultures of human proximal tubular cells. , 1997, Kidney international.

[9]  S. Warkentin,et al.  Functional imaging of the frontal lobes in organic dementia. Regional cerebral blood flow findings in normals, in patients with frontotemporal dementia and in patients with Alzheimer's disease, performing a word fluency test. , 1997, Dementia and geriatric cognitive disorders.

[10]  P. Gabow,et al.  Utility of ultrasonography in the diagnosis of autosomal dominant polycystic kidney disease in children. , 1997, Journal of the American Society of Nephrology : JASN.

[11]  P. Jungers,et al.  Factors influencing progression of renal failure in autosomal dominant polycystic kidney disease. , 1995, Journal of the American Society of Nephrology : JASN.

[12]  Ann M. Johnson,et al.  Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease. , 1994, Journal of the American Society of Nephrology : JASN.

[13]  R. Foley,et al.  Differences in hormonal and renal vascular responses between normotensive patients with autosomal dominant polycystic kidney disease and unaffected family members. , 1994, Kidney international.

[14]  Ann M. Johnson,et al.  The spectrum of autosomal dominant polycystic kidney disease in children. , 1994, Journal of the American Society of Nephrology : JASN.

[15]  W. Bennett,et al.  Surgical management of painful polycystic kidneys. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  T. Hostetter,et al.  Effect of angiotensin II and norepinephrine on early growth response genes in the rat kidney. , 1993, Kidney international.

[17]  G. Wolf,et al.  Angiotensin II as a hypertrophogenic cytokine for proximal tubular cells. , 1993, Kidney international. Supplement.

[18]  S. Geberth,et al.  Renal histology in polycystic kidney disease with incipient and advanced renal failure. , 1992, Kidney international.

[19]  Ann M. Johnson,et al.  Clinical profiles of gross hematuria in autosomal dominant polycystic kidney disease. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[20]  J. Mcateer,et al.  Synthesis of renin by tubulocystic epithelium in autosomal-dominant polycystic kidney disease. , 1992, Kidney international.

[21]  Ann M. Johnson,et al.  Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. , 1992 .

[22]  P. Allan,et al.  Effects of angiotensin converting enzyme inhibition in adult polycystic kidney disease. , 1992, Kidney international.

[23]  A. Chapman,et al.  Pathogenesis of hypertension in autosomal dominant polycystic kidney disease. , 1991, Seminars in nephrology.

[24]  K. Offord,et al.  Effect of inhibition of converting enzyme on renal hemodynamics and sodium management in polycystic kidney disease. , 1991, Mayo Clinic proceedings.

[25]  R. Harris,et al.  Angiotensin actions in the kidney: renewed insight into the old hormone. , 1991, Kidney international.

[26]  Ann M. Johnson,et al.  Renal structure and hypertension in autosomal dominant polycystic kidney disease. , 1990, Kidney international.

[27]  Ann M. Johnson,et al.  The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease. , 1990, The New England journal of medicine.

[28]  James R. Thompson Empirical Model Building , 1989 .

[29]  G. Lindop,et al.  The anatomy of the renin-secreting cell in adult polycystic kidney disease. , 1988, Kidney international.

[30]  L. Brion,et al.  The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. , 1987, Pediatric clinics of North America.

[31]  P. Gabow,et al.  Autosomal dominant polycystic kidney disease in childhood: a longitudinal study. , 1987, Kidney international.

[32]  W. Bennett,et al.  Reduction of cyst volume for symptomatic management of autosomal dominant polycystic kidney disease. , 1987, The Journal of urology.

[33]  J. Lott,et al.  Evaluation of the Coomassie Brilliant Blue G-250 method for urinary protein. , 1983, Clinical chemistry.

[34]  J B Stokes,et al.  The national high blood pressure education program. , 1974, Journal of the American Pharmaceutical Association.